Frontlight ResearchEarly access
Trial site
True North Clinical Research - New Minas
- 5closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Mild cognitive impairment2 trials
- Phase
- Phase 34 trials
- Phase 21 trial
- Status
- Completed3 trials
- Terminated2 trials
- Lead sponsor
- Cassava Sciences, Inc.2 trials
- Novo Nordisk A/S2 trials
- Alector Inc.1 trial
Closed trials
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Terminated
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026